Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar

Table 1 Reported antimalarial treatment practices of health care providers in six study sites of three states/regions, Myanmar (n = 32)

Health care	Treatment	Study region A	Study region B	Study region C	Total
Confirmed uncomplicated falciparum malaria
Public sector (n = 24)	ACT + PQ (correct dose and course)	6/6 (100%)	10/10 (100%)	8/8 (100%)	24/24 (100%)
Public sector (n = 24)	Artesunate 2 tds × 3 days	0	0	0	0
Private sector (n = 8)	ACT + PQ (correct dose and course)	1/2 (50%)	1/2 (50%)	3/4 (75%)	5/8 (65%)
Confirmed vivax malaria
Public sector (n = 24)	CQ + PQ (correct dose and course)	8/8 (100%)	5/5 (100%)	11/11 (100%)	24/24 (100%)
Public sector (n = 24)	CQ only	0	0	0	0
Private sector (n = 8)	CQ + PQ (correct dose and course)	0/3	0/4	0/1	0/8
Private sector (n = 8)	CQ only	0	0	0	0

ACT artemisinin combination treatment, PQ primaquine, CQ chloroquine, tds three times a day

ISSN: 1349-4147